SCHEMBL6511319

SCHEMBL6511319

C1=CC2NC3C=NC=CC3C2C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2188862 0.89
SCHEMBL2307623 0.78
SCHEMBL6373519 0.74
SCHEMBL278413 0.68
SCHEMBL3465341 0.67
SCHEMBL17839410 0.65
SCHEMBL14138851 0.63
SCHEMBL2281780 0.59
SCHEMBL991862 0.56
SCHEMBL13879644 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2025000782-A REGIMENS OF ESTROGEN RECEPTOR ANTAGONISTS オレマ ファーマシューティカルズ インク. 2025-01-07 JP disclosed
US-20050032790-A1 For example, 1-(2-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4,4'-bispiperidine; for treatment of thrombosis, emphysema, cirrhosis; antiarthritic agents, anticancer agents, antihistamines LIEBESCHUETZ JOHN WALTER (GB) 2005-02-10 US disclosed